Transcription factor TFIIH components enhance the GR coactivator activity but not the cell cycle-arresting activity of the human immunodeficiency virus type-1 protein Vpr

Biochemical and Biophysical Research Communications

Volumn 298, Issue 1, 2002, Pages 17-23

  Kino, Tomoshige ^a   Tsukamoto, Makoto ^b   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CDK7; Cell cycle arrest; Coactivator; Cyclin H; MAT1

Indexed keywords

GLUCOCORTICOID RECEPTOR; MUTANT PROTEIN; PHOSPHOTRANSFERASE; PROTEIN P300; RNA POLYMERASE II; TRANSCRIPTION FACTOR; VIRUS PROTEIN; VPR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ACTIVITY; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

BINDING SITES; CELL CYCLE; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE PRODUCTS, VPR; HELA CELLS; HIV-1; HUMANS; MACROMOLECULAR SUBSTANCES; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RECEPTORS, GLUCOCORTICOID; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS, TFII; TUMOR CELLS, CULTURED;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036402949     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02442-7     Document Type: Article

References (43)

1. J.S. Gibbs, A.A. Lackner, S.M. Lang, M.A. Simon, P.K. Sehgal, M.D. Daniel, R.C. Desrosiers, Progression to AIDS in the absence of a gene for Vpr or Vpx, J. Virol. 69 (1995) 2378-2383.
2. W.C. Goh, M.E. Rogel, C.M. Kinsey, S.F. Michael, P.N. Fultz, M.A. Nowak, B.H. Hahn, M. Emerman, HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo, Nat. Med. 4 (1998) 65-71.
3. N.K. Heinzinger, M.I. Bukinsky, S.A. Haggerty, A.M. Ragland, V. Kewalramani, M.A. Lee, H.E. Gendelman, L. Ratner, M. Stevenson, M. Emerman, The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells, Proc. Natl. Acad. Sci. USA 91 (1994) 7311-7315.
4. E.A. Cohen, G. Dehni, J.G. Sodroski, W.A. Haseltine, Human immunodeficiency virus Vpr product is a virion-associated regulatory protein, J. Virol. 64 (1990) 3097-3099.
5. W. Paxton, R.I. Connor, N.R. Landau, Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis, J. Virol. 67 (1993) 7229-7237.
6. V. Ayyavoo, S. Mahalingam, Y. Rafaeli, S. Kudchodkar, D. Chang, T. Nagashunmugam, W.V. Williams, D.B. Weiner, HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro, J. Leukoc. Biol. 62 (1997) 93-99.
7. E.A. Cohen, R.A. Subbramanian, H.G. Gottlinger, Role of auxiliary proteins in retroviral morphogenesis, Curr. Top. Microbiol. Immunol. 214 (1996) 219-235.
8. M. Emerman, HIV-1, Vpr and the cell cycle, Curr. Biol. 6 (1996) 1096-1103.
9. G.N. Pavlakis, The molecular biology of HIV-1, in: V.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.), AIDS: Diagnosis, Treatment, and Prevention, Lippincott Raven, Philadelphia, 1996, pp. 45-74.
10. S.A. Stewart, B. Poon, J.B. Jowett, Y. Xie, I.S. Chen, Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells, Proc. Natl. Acad. Sci. USA 96 (1999) 12039-12043.
11. T. Kino, A. Gragerov, J.B. Kopp, R.H. Stauber, G.N. Pavlakis, G.P. Chrousos, The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor, J. Exp. Med. 189 (1999) 51-62.
12. N.J. McKenna, J. Xu, Z. Nawaz, S.Y. Tsai, M.J. Tsai, B.W. O3Malley, Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions, J. Steroid Biochem. Mol. Biol. 69 (1999) 3-12.
13. T. Kino, A. Gragerov, O. Slobodskaya, M. Tsopanomichalou, G.P. Chrousos, G.N. Pavlakis, Human immunodeficiency virus type-1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators, J. Virol. 76 (2002) 9724-9734.
14. cdc2 activity, J. Virol. 69 (1995) 6705-6711.
15. J.B. Jowett, V. Planelles, B. Poon, N.P. Shah, M.L. Chen, I.S. Chen, The human immunodeficiency virus type 1 Vpr gene arrests infected T cells in the G2 + M phase of the cell cycle, J. Virol. 69 (1995) 6304-6313.
16. cdc2-Cyclin B, J. Virol. 69 (1995) 6859-6864.
17. M.E. Rogel, L.I. Wu, M. Emerman, The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection, J. Virol. 69 (1995) 882-888.
18. M. Hrimech, X.J. Yao, P.E. Branton, E.A. Cohen, Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A, EMBO J. 19 (2000) 3956-3967.
19. M. Masuda, Y. Nagai, N. Oshima, K. Tanaka, H. Murakami, H. Igarashi, H. Okayama, Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr, J. Virol. 74 (2000) 2636-2646.
20. A. Gragerov, T. Kino, G. Ilyina-Gragerova, G.P. Chrousos, G.N. Pavlakis, HHR23A, the human homologue of the yeast repair protein RAD23 interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr, Virology 245 (1998) 323-330.
21. E.S. Withers-Ward, J.B. Jowett, S.A. Stewart, Y.M. Xie, A. Garfinkel, Y. Shibagaki, S.A. Chow, N. Shah, F. Hanaoka, D.G. Sawitz, R.W. Armstrong, L.M. Souza, I.S. Chen, Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair, J. Virol. 71 (1997) 9732-9742.
22. A.R. Lehmann, Nucleotide excision repair and the link with transcription, Trends Biochem. Sci. 20 (1995) 402-405.
23. P.K. Bhatia, Z. Wang, E.C. Friedberg, DNA repair and transcription, Curr. Opin. Genet. Dev. 6 (1996) 146-150.
24. J.Q. Svejstrup, P. Vichi, J.M. Egly, The multiple roles of transcription/repair factor TFIIH, Trends Biochem. Sci. 21 (1996) 346-350.
25. S. Larochelle, J. Chen, R. Knights, J. Pandur, P. Morcillo, H. Erdjument-Bromage, P. Tempst, B. Suter, R.P. Fisher, T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity, EMBO J. 20 (2001) 3749-3759.
26. D.K. Lee, H.O. Duan, C. Chang, From androgen receptor to the general transcription factor TFIIH. Identification of CDK activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator, J. Biol. Chem. 275 (2000) 9308-9313.
27. D. Chen, T. Riedl, E. Washbrook, P.E. Pace, R.C. Coombes, J.M. Egly, S. Ali, Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7, Mol. Cell 6 (2000) 127-137.
28. R. Roy, J.P. Adamczewski, T. Seroz, W. Vermeulen, J.P. Tassan, L. Schaeffer, E.A. Nigg, J.H. Hoeijmakers, J.M. Egly, The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor, Cell 79 (1994) 1093-1101.
29. R. Drapkin, G. Le Roy, H. Cho, S. Akoulitchev, D. Reinberg, Human cyclin-dependent kinase-activating kinase exists in three distinct complexes, Proc. Natl. Acad. Sci. USA 93 (1996) 6488-6493.
30. M. Rossignol, I. Kolb-Cheynel, J.M. Egly, Substrate specificity of the CDK-activating kinase (CAK) is altered upon association with TFIIH, EMBO J. 16 (1997) 1628-1637.
31. J.A. Ranish, S. Hahn, Transcription: basal factors and activation, Curr. Opin. Genet. Dev. 6 (1996) 151-158.
32. A.J. Koleske, R.A. Young, An RNA polymerase II holoenzyme responsive to activators, Nature 368 (1994) 466-469.
33. D. Tantin, M. Carey, A heteroduplex template circumvents the energetic requirement for ATP during activated transcription by RNA polymerase II, J. Biol. Chem. 269 (1994) 17397-17400.
34. F.C. Holstege, D. Tantin, M. Carey, P.C. van der Vliet, H.T. Timmers, The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA, EMBO J. 14 (1995) 810-819.
35. T.P. Makela, J.D. Parvin, J. Kim, L.J. Huber, P.A. Sharp, R.A. Weinberg, A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription, Proc. Natl. Acad. Sci. USA 92 (1995) 5174-5178.
36. J. Bastien, S. Adam-Stitah, T. Riedl, J.M. Egly, P. Chambon, C. Rochette-Egly, TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through CDK7, J. Biol. Chem. 275 (2000) 21896-21904.
37. C. Rochette-Egly, S. Adam, M. Rossignol, J.M. Egly, P. Chambon, Stimulation of RAR α activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7, Cell 90 (1997) 97-107.
38. M.P. Cosma, Ordered recruitment: gene-specific mechanism of transcription activation, Mol. Cell 10 (2002) 227-236.
39. Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, M. Brown, Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription, Cell 103 (2000) 843-852.
40. S. Popov, M. Rexach, L. Ratner, G. Blobel, M. Bukrinsky, Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex, J. Biol. Chem. 273 (1998) 13347-13352.
41. S. Popov, M. Rexach, G. Zybarth, N. Reiling, M.A. Lee, L. Ratner, C.M. Lane, M.S. Moore, G. Blobel, M. Bukrinsky, Viral protein R regulates nuclear import of the HIV-1 pre-integration complex, EMBO J. 17 (1998) 909-917.
42. M.A. Vodicka, D.M. Koepp, P.A. Silver, M. Emerman, HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection, Genes Dev. 12 (1998) 175-185.
43. R. Daniel, R.A. Katz, A.M. Skalka, A role for DNA-PK in retroviral DNA integration, Science 284 (1999) 644-647.